Aier Eye Hospital Group Co Ltd
SZSE:300015
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
EV/EBIT
Enterprise Value to EBIT (EV/EBIT) ratio compares a company`s total enterprise value to its earnings before interest and taxes. It shows how much investors are paying for each dollar of the company`s earnings, including both equity and debt.
Enterprise Value to EBIT (EV/EBIT) ratio compares a company`s total enterprise value to its earnings before interest and taxes. It shows how much investors are paying for each dollar of the company`s earnings, including both equity and debt.
Valuation Scenarios
If EV/EBIT returns to its 3-Year Average (25.7), the stock would be worth ¥12.48 (20% upside from current price).
| Scenario | EV/EBIT Value | Implied Price | Upside/Downside |
|---|---|---|---|
| Current Multiple | 21.4 | ¥10.41 |
0%
|
| 3-Year Average | 25.7 | ¥12.48 |
+20%
|
| 5-Year Average | 34 | ¥16.5 |
+59%
|
| Industry Average | 29.4 | ¥14.28 |
+37%
|
| Country Average | 28.9 | ¥14.03 |
+35%
|
Forward EV/EBIT
Today’s price vs future ebit
| Today's Enterprise Value | EBIT | Forward EV/EBIT | ||
|---|---|---|---|---|
|
¥89.8B
|
/ |
Oct 2025
¥4.5B
|
= |
|
|
¥89.8B
|
/ |
Dec 2025
¥5.1B
|
= |
|
|
¥89.8B
|
/ |
Dec 2026
¥5.9B
|
= |
|
|
¥89.8B
|
/ |
Dec 2027
¥6.7B
|
= |
|
Forward EV/EBIT shows whether today’s EV/EBIT still looks high or low once future ebit are taken into account.
Peer Comparison
| Market Cap | EV/EBIT | P/E | ||||
|---|---|---|---|---|---|---|
| CN |
A
|
Aier Eye Hospital Group Co Ltd
SZSE:300015
|
97.1B CNY | 21.4 | 30.2 | |
| US |
|
HCA Healthcare Inc
NYSE:HCA
|
108.2B USD | 11.6 | 14.7 | |
| SA |
|
Dr Sulaiman Al-Habib Medical Services Group Co
SAU:4013
|
98B SAR | 40 | 40.8 | |
| ZA |
N
|
Netcare Ltd
JSE:NTC
|
23.8B ZAR | 9.4 | 14.2 | |
| MY |
I
|
IHH Healthcare Bhd
KLSE:IHH
|
78.2B MYR | 22.9 | 37.2 | |
| ZA |
L
|
Life Healthcare Group Holdings Ltd
JSE:LHC
|
17.8B ZAR | -52.9 | 4.6 | |
| BR |
|
Rede D'Or Sao Luiz SA
BOVESPA:RDOR3
|
83.5B BRL | 9.1 | 17.9 | |
| US |
|
Tenet Healthcare Corp
NYSE:THC
|
16.4B USD | 6.8 | 11.1 | |
| IN |
|
Apollo Hospitals Enterprise Ltd
NSE:APOLLOHOSP
|
1.1T INR | 43.1 | 61.6 | |
| US |
|
Universal Health Services Inc
NYSE:UHS
|
11.1B USD | 7.3 | 7.1 | |
| US |
|
Ensign Group Inc
NASDAQ:ENSG
|
11B USD | 24.5 | 31.6 |
Market Distribution
| Min | 0 |
| 30th Percentile | 16.6 |
| Median | 28.9 |
| 70th Percentile | 52.9 |
| Max | 49 021 |
Other Multiples
Aier Eye Hospital Group Co Ltd
Glance View
Aier Eye Hospital Group Co., Ltd., having risen prominently in the medical services sector, narrates a compelling story of growth and innovation. Founded in 2003 and headquartered in Changsha, China, Aier Eye Hospital embodies the vision of providing comprehensive eye care services across the nation and beyond. Its journey began with a singular focus on ophthalmology, and over the years, it meticulously expanded its network, now operating hundreds of specialized eye clinics and hospitals domestically and internationally. This network offers services ranging from basic eye examinations to complex surgeries, such as cataract removal and refractive surgery. The company reached a notable milestone by successfully integrating modern medical technology with a patient-centric service model, ensuring that its facilities are equipped with state-of-the-art technology to deliver high-quality ophthalmic care. Aier Eye Hospital derives its revenue primarily from providing these medical services, supported by strategic acquisitions and partnerships that enhance its spectrum of offerings and geographic footprint. Its business model deftly combines volume-driven profitability with high-quality care, allowing it to maintain a leadership position in the industry. Education and research form additional pillars of its operational strategy; Aier emphasizes the continuous training of its medical staff and engages in research initiatives, thus fostering an environment of innovation that further solidifies its competitive edge. This blend of strategic growth, patient-focused service, and technological advancement enables Aier Eye Hospital Group to not only cater to a growing demand for eye care services but also chart a course of sustained financial health and expansion.